Passage Bio Inc (PASG)

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

BioSpace

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

BioSpace

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

BioSpace

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

BioSpace

Wedbush Weighs in on Passage Bio, Inc.'s Q2 2024 Earnings (NASDAQ:PASG) - MarketBeat

MarketBeat

All You Need to Know About Passage Bio (PASG) Rating Upgrade to Buy - Yahoo Finance UK

Yahoo Finance UK

Passage Bio, Inc. (NASDAQ:PASG) to Post Q2 2024 Earnings of ($0.29) Per Share, Wedbush Forecasts - Defense World

Defense World

Passage Bio Reports Promising Interim Data in FTD-GRN Treatment Trial - MyChesCo

MyChesCo

Passage Bio (NASDAQ:PASG) Price Target Cut to $13.00 by Analysts at Canaccord Genuity Group - MarketBeat

MarketBeat

Equities Analysts Issue Forecasts for Passage Bio, Inc.'s Q1 2025 Earnings (NASDAQ:PASG) - MarketBeat

MarketBeat

Biopharma Layoff Tracker 2024: Bolt, Tenaya, BioMarin and More Cut Staff - BioSpace

BioSpace

Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - Yahoo Finance

Yahoo Finance

Passage Bio (NASDAQ:PASG) Shares Up 0.7% - MarketBeat

MarketBeat

Recent Insider Activity Suggests Potential Gains for Passage Bio Inc (PASG) – Knox Daily - Knox Daily

Knox Daily

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

GlobeNewswire Inc.

Passage Bio to Present at Chardan's 8th Annual Genetic - GlobeNewswire

GlobeNewswire

Smartphone Tests Detect Frontotemporal Dementia - Medpage Today

Medpage Today

Leadership | BioMarin - Investor Relations : BioMarin

Investor Relations : BioMarin

Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should Know - Yahoo Finance

Yahoo Finance

Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program - BioBuzz

BioBuzz

Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights

GlobeNewswire Inc.

Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights - Yahoo Finance

Yahoo Finance

Passage Bio to Participate in Upcoming Investor Conferences

GlobeNewswire Inc.

Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032 ... - GlobeNewswire

GlobeNewswire

Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire Inc.

Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - GlobeNewswire

GlobeNewswire

Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket

Benzinga

Passage Bio reports data from FTD-GRN gene therapy trial - Clinical Trials Arena

Clinical Trials Arena

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities

GlobeNewswire Inc.

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated ... - GlobeNewswire

GlobeNewswire

Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights - Yahoo Finance

Yahoo Finance

Frontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032 ... - GlobeNewswire

GlobeNewswire

Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and ... - PR Newswire

PR Newswire

Ann Lee-Karlon named CEO of EpiBiologics - BioCentury

BioCentury

30+ Best Stocks Under $2 to Invest in 2023 - Stocks Telegraph

Stocks Telegraph

Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo

Yahoo

Passage Bio Seeks Pennsylvania College Student Candidates for Second Annual Tachi Yamada Scholarship Program - Yahoo

Yahoo

Passage Bio to Present at Cowen 43rd Annual Health Care Conference - Yahoo

Yahoo

Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual ... - MyChesCo

MyChesCo

Rough Passage: Gene Therapy Developer Hunkers Down after Job, Pipeline Cuts - Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News

Fierce Biotech Layoff Tracker: Layoffs strike 119 companies in 2022 - Fierce Biotech

Fierce Biotech

Thomas Woiwode Net Worth (2024) - GuruFocus.com

GuruFocus.com

Movers & Shakers: CEO Shakeups at BIO, Passage Bio and Palisade Bio - BioSpace

BioSpace

Power Moves: Burro hired its new VP of engineering from Toyota Research Institute - Technical.ly

Technical.ly

Passage Bio Appoints William Chou CEO - citybiz

citybiz

Passage Bio and CEO Bruce Goldsmith part ways - Philadelphia Business Journal - The Business Journals

The Business Journals

Five Philly Gene Therapy Companies You Should Know - BioBuzz

BioBuzz

Leaked reports allege that Penn officials led 'shameless cover-up' to protect Gene Therapy Program - The Daily Pennsylvanian

The Daily Pennsylvanian

Frontotemporal Dementia Pipeline Landscape Analysis of 20+ Companies by DelveInsight - GlobeNewswire

GlobeNewswire

Investors Eye Gene Therapy Companies and Rapidly Expanding Market - BioBuzz

BioBuzz